Raised levels of serum NfL (sNfL) have been found in numerous acute and chronic neurologic diseases, including in adults with mild-to-moderate and severe COVID-19 [7, 8]; levels in pediatric COVID-19 and PMIS have not as yet been reported. This evidence concerns the gene NEFL and COVID-19.